PITTSBURGH, Oct. 26, 2022 (GLOBE NEWSWIRE) — Coherent Corp. (Nasdaq: COHR), a global leader in materials, networking, and laser technology, announced today that the company will hold a conference call on Wednesday, November 9, 2022, at 9:00 a.m. ET. The call will be hosted by Dr. Vincent D. (Chuck) Mattera, Jr., Chair and CEO and Mary Jane Raymond, Chief Financial Officer. Dr. Giovanni Barbarossa, Chief Strategy Officer and President, Materials Segment and Dr. Mark Sobey, President, Lasers Segment will participate in the question and answer session.
The first-quarter results for FY 2023 will be released before the market opens on Wednesday, November 9, 2022, and will be posted on the company’s website at www.coherent.com/company/investor-relations.
Individuals wishing to listen to the live webcast of the call can access the event at the company’s website by visiting www.coherent.com/company/investor-relations or via this link. Equity analysts and others who wish to participate in the question-and-answer session of the conference call can pre-register at this link to receive dial-in numbers and a unique PIN.
The call will be recorded, and a replay will be available to interested parties who are unable to attend the live event. This service will be available on the company’s website beginning November 9, 2022, at 4:00 p.m. ET.
About Coherent
Coherent empowers market innovators to define the future through breakthrough technologies, from materials to systems. We deliver innovations that resonate with our customers in diversified applications for the industrial, communications, electronics, and instrumentation markets. Headquartered in Saxonburg, Pennsylvania, Coherent has research and development, manufacturing, sales, service, and distribution facilities worldwide. For more information, please visit us at www.coherent.com.
Forward-looking Statements
This press release contains forward-looking statements relating to future events and expectations that are based on certain assumptions and contingencies. The forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 and relate to the company’s performance on a going-forward basis. The forward-looking statements in this press release involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures.
The company believes that all forward-looking statements made by it in this press release have a reasonable basis, but there can be no assurance that management’s expectations, beliefs, or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and global economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this press release include but are not limited to: (i) the failure of any one or more of the assumptions stated herein to prove to be correct; (ii) the risks relating to forward-looking statements and other “Risk Factors” discussed in the company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2022, and additional risk factors that may be identified from time to time in filings of the company; (iii) the substantial indebtedness the company incurred in connection with its acquisition of Coherent, Inc. (the “Transaction”), and the need to generate sufficient cash flows to service and repay such debt; (iv) the possibility that the company may be unable to achieve expected synergies, operating efficiencies, and other benefits within the expected time frames or at all and to successfully integrate operations of Coherent, Inc. (“Coherent”), with those of the company; (v) the possibility that such integration may be more difficult, time-consuming, or costly than expected or that operating costs and business disruption (including, without limitation, disruptions in relationships with employees, customers, or suppliers) may be greater than expected in connection with the Transaction; (vi) any unexpected costs, charges, or expenses resulting from the Transaction; (vii) the risk that disruption from the Transaction materially and adversely affects the respective businesses and operations of the company and Coherent; (viii) potential adverse reactions or changes to business relationships resulting from the completion of the Transaction; (ix) the ability of the company to retain and hire key employees; (x) the purchasing patterns of customers and end users; (xi) the timely release of new products, and acceptance of such new products by the market; (xii) the introduction of new products by competitors and other competitive responses; (xiii) the company’s ability to assimilate recently acquired businesses, and realize synergies, cost savings, and opportunities for growth in connection therewith, together with the risks, costs, and uncertainties associated with such acquisitions; (xiv) the company’s ability to devise and execute strategies to respond to market conditions; (xv) the risks to realizing the benefits of investments in R&D and commercialization of innovations; (xvi) the risks that the company’s stock price will not trade in line with industrial technology leaders; and/or (xvii) the risks of business and economic disruption related to the currently ongoing COVID-19 outbreak and any other worldwide health epidemics or outbreaks that may arise. The company disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events or developments, or otherwise.
Contact
Mary Jane Raymond
Chief Financial Officer
[email protected]
- Dogwood Health Trust Announces More Than $30 Million for Initial Hurricane Helene Relief Funding Throughout Western North Carolina - October 4, 2024
- ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX - October 4, 2024
- Elevai Labs Inc. Commences Offer to Exchange Up to 15,000,000 shares of Common Stock For Shares of Non Tradable. Locked Up Series B Preferred Stock - October 4, 2024